Effects of a predictive preventive model for prevention of Clostridium difficile infection in patients in intensive care units

American Journal of Infection Control

Volumn 44, Issue 4, 2016, Pages 421-424

  Cruz Betancourt, Alba ^a   Cooper, Christopher D ^a   Sposato, Kathleen ^a   Milton, Hermanda ^a   Louzon, Patricia ^a   Pepe, Julie ^a   Girgis, Ramy ^a   Patel, Seema V ^a   Ibrahim, Dina ^a   Van Horn, Sandra ^a   Hsu, Vincent ^a  

^a FLORIDA HOSPITAL   (United States)

Author keywords

CDI; HA CDI; multidisciplinary; screening tool

Indexed keywords

ANTIBIOTIC AGENT; PROBIOTIC AGENT;

ARTICLE; ARTIFICIAL VENTILATION; CLOSTRIDIUM DIFFICILE INFECTION; CRITICALLY ILL PATIENT; HEALTHCARE ASSOCIATED INFECTION; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; PATIENT CARE; PEPTOCLOSTRIDIUM DIFFICILE; PREDICTION; RETROSPECTIVE STUDY; SCREENING; AGED; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DECISION SUPPORT SYSTEM; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HETEROZYGOTE; INFECTION CONTROL; ISOLATION AND PURIFICATION; MALE; MASS SCREENING; MIDDLE AGED; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARRIER STATE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DECISION SUPPORT TECHNIQUES; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; MALE; MASS SCREENING; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84952883329     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2015.11.010     Document Type: Article

References (17)

1. 1 Dubberke, E.R., Butler, A.M., Reske, K.A., Agniel, D., Olsen, M.A., D'Angelo, G., et al. Attributable outcomes of endemic Clostridium difficile–associated disease in non-surgical patients. Emerg Infect Dis 14 (2008), 1031–1038.
2. 2 Dubberke, E.R., Olsen, M.A., Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 55:Suppl 2 (2012), S88–92.
3. 3 Chandra, S., Thapa, R., Marur, S., Jani, N., Validation of a clinical prediction scale for hospital-onset Clostridium difficile infection. J Clin Gastroenterol 48 (2014), 419–422.
4. 4 Bartlett, J.G., Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 145 (2006), 758–764.
5. 5 Cohen, S., Gerding, D., Johnson, S., Kelly, C., Loo, V., McDonald, L., Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society of Healthcare Epidemiology of America (SHEA) and the IDSA. Infect Control Hosp Epidemiol 31 (2010), 431–455.
6. 6 Pepin, J., Saheb, N., Coulombe, M.A., Alary, M.E., Corriveau, M.P., Authier, S., et al. Emergence of flouroquinolones as the predominant risk factor for Clostridium difficile-associate diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41 (2005), 1254–1260.
7. 7 Cadle, R.M., Mansouri, M.D., Logan, N., Kudva, R., Musher, D.M., Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis. Am J Health Syst Pharm 64 (2007), 2359–2363.
8. 8 Barbut, F., Petit, J.C., Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect 7 (2001), 405–410.
9. 9 Riddle, D., Dubberke, E., Clostridium difficile infection in the intensive care unit. Infect Dis Clin North Am 23 (2009), 727–743.
10. 10 Dubberke, E.R., Carling, P., Carrico, R., Donskey, C.J., Loo, V.G., McDonald, L.C., et al. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 35 (2014), 628–645.
11. 11 Johnson, S., Maziade, P.J., McFarland, L.V., Trick, W., Donskey, C., Currie, B., et al. Is primary prevention of Clostridium difficile infection possible with specific probiotics?. Int J Infect Dis 16 (2012), e786–92.
12. 12 Howe, P., Developing and maintaining the Kettering infection predictor tool. Nurs Stand 27 (2013), 35–41.
13. 13 Center for Disease Control/National Healthcare Safety Network (CDC/NHSN), Multi-drug-resistant organism & Clostridium difficile infection (MDRO/CD) Module. Available from: www.cdc.gov/nhsn/PDFs/pscManual/12pscMDRO_CDADcurrent.pdf, 2015 Accessed July 10, 2015.
14. 14 Jabbar, U., Leischner, J., Kasper, D., Gerber, R., Sambol, S.P., Parada, J.P., et al. Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol 31 (2010), 565–570.
15. 15 Tabak, Y.P., Johannes, R.S., Sun, X., Nunez, C.M., McDonald, L.C., Predicting the risk for hospital-onset Clostridium difficile infection (HO-CDI) at the time of inpatient admission: HO-CDI risk score. Infect Control Hosp Epidemiol 36 (2015), 695–701.
16. 16 Zilberberg, M.D., Reske, K., Olsen, M., Yan, Y., Dubberke, E.R., Development and validation of a recurrent Clostridium difficile risk-prediction model. J Hosp Med 9 (2014), 418–423.
17. 17 Power, M., Wigglesworth, N., Donaldson, E., Chadwick, P., Gillibrand, S., Goldmann, D., Reducing Clostridium difficile infection in acute care by using an improvement collaborative. BMJ, 341, 2010, c3359.